Skip to main content
Clinical Trials/NCT00541645
NCT00541645
Suspended
Not Applicable

Transient Osteoporosis of Pregnancy: A Possible Peptide Mediator

Hadassah Medical Organization0 sitesOctober 10, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Transient Osteperosis
Sponsor
Hadassah Medical Organization
Status
Suspended
Last Updated
18 years ago

Overview

Brief Summary

Transient osteoporosis of pregnancy (TOoP) is uncommonly encountered in orthopedic and obstetric practice, with most reports consisting of single cases.

This rare condition consists of significant osteoporosis affecting the hips and spine, causing significant morbidity, and putting young female patients at risk for vertebral and femoral neck fractures.

The pathogenesis of transient osteoporosis of pregnancy is unknown, with various theories as to its etiology.

Recently, a number of reports have described elevated levels of PTHrP in patients with transient osteoporosis in pregnancy and of the postpartum period Our goal in this study is to assess the role of PTHrP in transient osteoporosis of pregnancy

Registry
clinicaltrials.gov
Start Date
October 10, 2007
End Date
TBD
Last Updated
18 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Signed Informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials